Two consecutive clinical trials on cisplatin (CDDP), hepatic arterial infusion (HAI), and i.v. 5-fluorouracil (5-FU) chemotherapy for unresectable colorectal liver metastases: an alternative to FUdR-based regimens?
Cosimelli
M
M
Regina Elena Cancer Institute, Rome, Italy.
Mannella
E
E
Anzá
M
M
Civalleri
D
D
Balletto
N
N
Di Tora
P
P
Durante
F
F
Porcellana
M
M
Cavaliere
P
P
Anfossi
A
A
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D015179:Colorectal Neoplasms / Q000473:pathology*; D004341:Drug Evaluation; D005467:Floxuridine; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D007261:Infusions, Intra-Arterial; D008113:Liver Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000556:secondary*; D008875:Middle Aged; D009944:Organoplatinum Compounds / Q000008:administration & dosage; D015996:Survival Rate
D009944:Organoplatinum Compounds; D005467:Floxuridine; C055423:didimethylsulfoxide dichloroplatinum(II); D005472:Fluorouracil